Patent Assignment
Reel/Frame 029908/0217
Assignment of Assignor's Interest
Recorded: 2013-03-01
Received: 2013-03-01
Pages: 4
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-04-01
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
ALFRED NOBEL STRASSE 10, MONHEIM, DEX, 40789, GERMANY
Covered Properties
(28)
Aqueous Formulations of (2-Hydroxymethyl-Indanyl-4-Oxy)-Phenyl-4,4,4-Trifluorobutane-1-Sulfonate
Application:
12/949,773 →
Amides of Acetic and Propionic Acids
Application:
12/494,009 →
Heteroaryl Carboxamides
Application:
11/891,527 →
Novel Dicarboxylic Acid Derivatives with Pharmaceutical Properties
Application:
11/823,462 →
Substituted 2, 6-Diamino-3, 5-Dicyano-4-Arylpyridines and Their Use as Adenosine-Receptor-Selective Ligands
Application:
11/607,262 →
Medicaments Containing Vardenafil Hydrochloride Trihydrate
Application:
10/521,534 →
Carbamate-Substituted Pyrazolopyridines
Application:
10/513,869 →
Substituted 2-Thio-3,5-Dicyano-4-Phenyl-6-Aminopyridines and the Use of the Same
Application:
10/497,120 →
Derivatives of 2-(1-Benzyl-1H-Pyrazolo(3,4-B)Pyridine-3-Yl)- 5(-4-Pyridiny)L-4- Pyrimidinamines and the Use Thereof as Quanylate Cyclase Stimulators
Application:
10/514,909 →
Heteroaryl Carboxylic Acid Amides
Application:
10/496,404 →
Amides of Acetic and Propionic Acids
Application:
10/508,106 →
Process for the Preparation of Sulphonamide-Substituted Imidazotriazinones
Application:
11/124,452 →
Aza-Bicyclic N-Biarylamides with Affinity for the Alpha-7 Nicotinic Acetylcholine Receptor
Application:
10/508,108 →
2-Heteroarylcarboxylic Acid Amides
Application:
10/500,096 →
Bicyclic N-Arylamides
Application:
10/497,511 →
Method for Separating Methyl 4-(2-Chloro-4-Fluorophenyl)-2-(3,5-Difluoro-2-Pyridinyl)-6-Methyl-1,4-Dihydro-5-Pyrimidine-Carboxylate-Racemate
Application:
10/478,602 →
Process for Renaturation of Recombinant, Disulfide Containing Proteins at High Protein Concentrations in the Presence of Amines
Application:
10/495,417 →
Method for the Production of 2-(2-Ethoxyphenyl)-Substituted Imidazotriazinones
Application:
10/451,706 →
Fluorescence-Measuring System
Application:
10/444,681 →
Purification of Protein Inclusion Bodies by Crossflow Microfiltration
Application:
10/275,797 →
Integrin-Mediated Drug Targeting
Application:
10/070,208 →
Novel Cytostatic Conjugates with Integrin Ligands
Application:
10/096,120 →
Aqueous Pharmaceutical Composition Containing Moxifloxacin or Salts Thereof
Application:
10/049,094 →
Moxifloxacin Formulation Containing Common Salt
Application:
10/049,095 →
Process for the Preparation of Sulphonamide-Substituted Imidazotriazinones
Application:
10/022,954 →
Method for the Enantiomer Separation of Cis-8-Benzyl-7,9-Dioxo-2,8-Diazabicyclo[4.3.0]Nonane
Application:
10/018,110 →
Pharmaceutical Moxifloxacin Preparation
Application:
09/830,770 →
Substituted Pyrazole Derivatives Condensed with Six-Membered Heterocyclic Rings
Application:
09/744,830 →